Cornelia Liu Trimble, M.D.

• Professor of Gynecology and Obstetrics

https://www.hopkinsmedicine.org/profiles/results/directory/profile/0007730/angelo-demarzo

Healthrelated quality of life measurement in women with polycystic ovary syndrome: A systematic review erectile dysfunction doctor milwaukee order on line super levitra. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism erectile dysfunction medication does not work generic super levitra 80 mg. Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: An analysis of 263 consecutive cases erectile dysfunction from nerve damage purchase genuine super levitra line. Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss erectile dysfunction treatment south florida generic 80 mg super levitra visa. Best practice options for hair removal in patients with unwanted facial hair using combination therapy with laser: Guidelines drawn up by an expert working group erectile dysfunction treatment cincinnati order super levitra with a visa. Spironolactone is an effective and well tolerated systemic antiandrogen therapy for Hirsute women. Cyproterone acetate for severe hirsutism: Results of a double-blind dose-ranging study. Cyproterone acetate/ ethinyl estradiol for acne and hirsutism: Time to revise prescribing policy. Clinical review: Antiandrogens for the treatment of hirsutism: A systematic review and metaanalyses of randomized controlled trials. Metformin versus oral contraceptive pill in polycystic ovary syndrome: A Cochrane review. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome Their prevention and treatment require an understanding of the physiology of pregnancy and its relation to the pathophysiology of the condition. Pregnancy is associated with extensive maternal physiological changes to accommodate the needs of the mother and fetus. The maternal endocrine adaptations in pregnancy have both causal and reactive elements. Many of the endocrine diseases occurring in women of childbearing age can lead to subfertility; therefore, preexisting endocrine conditions may need special interventions to facilitate ovulation. If these conditions remain untreated, they can lead to serious morbidity and mortality for both mother and fetus; therefore, early recognition is imperative. Endocrine complications in pregnancy represent a useful paradigm to address all medical complications of pregnancy. After addressing the pathophysiology of the condition in pregnancy, it is useful to consider each of the maternal issues, fetal issues, obstetric issues, and finally the effect of having the condition in pregnancy in the long term for the condition itself. Gestational age may need to be considered, in diagnosis and management, particularly for surgical procedures that may be necessary during pregnancy (Box 19. The diagnosis of endocrine conditions presenting during pregnancy can pose challenges because biochemical testing may be limited in pregnancy. In addition, certain radiological investigations may be contraindicated in pregnancy, adding to the difficulties surrounding the diagnosis. Thyroid disease Pregnancy results in major alterations in maternal thyroid hormone physiology. Later in pregnancy as estrogen rises, so does the thyroid-binding globulin,4 due to reduced catabolism. The mother with less capacity of the thyroid to adapt may become relatively hypothyroid and would need to increase thyroid hormone replacement to compensate. This uptake can cause an iodine-insufficient mother to become an iodine-deficient mother. Thyroxine does cross the placenta, but the flow is limited by placental type 3 monodeiodinases. This can occur in utero, presenting with fetal tachycardia, and then continue into the first 2 weeks of life. Thyroid disease is one of the most common endocrine abnormalities found in pregnancy. The mother is relatively hyperthyroid in normal pregnancy, even when there is no thyroid pathology. Thyroid hormones are carried by several proteins, but the majority is carried by thyroid-binding globulin. Thyroid-binding globulin production is increased by estrogen, leading to an increased need for thyroid hormones. The normal hypothalamic Thyrotoxicosis (see Chapter 13) Thyrotoxicosis is a constellation of symptoms, signs, and risks resulting from excessive amounts of thyroid hormones. Clinical improvement tends to be in the second and third trimester, which is thought to be related to the reduction in levels of circulating thyroid-stimulating immunoglobulins. Untreated thyrotoxicosis may adversely affect the pregnancy, with increased rates of miscarriage, low birth weight, prematurity, eclampsia, and congenital birth defects. The placenta presents a relative barrier to high maternal circulating thyroid hormone concentrations. Pregnancy issues the hypermetabolic state of pregnancy can make the diagnosis of thyrotoxicosis difficult. Heat intolerance, warm skin, tachycardia, emotional lability, weight loss, diarrhea, and significant tachycardia and systolic flow murmurs may occur but may be seen in normal pregnancy, too. Gestational thyrotoxicosis may be found alone or with hyperemesis gravidarum and can occur at any stage in pregnancy but typically does not persist beyond 20 weeks of gestation. The diagnosis of thyrotoxicosis is made based on clinical findings and thyroid function tests. Women with hyperthyroidism could consider a definitive approach before conception (Box 19. Diagnosis Treatment -Blockers are important for symptom control and for rate control in the presence of significant maternal tachycardia. Surgery is ideally performed in the second trimester when organogenesis is complete; however, the dangers of severe untreated maternal thyrotoxicosis are considerable and surgery can be performed in the third trimester. Surgery is however associated with an increased risk of spontaneous abortion or premature delivery. The fetus of such a pregnancy may become thyrotoxic and develop a goiter in utero. Fetal tachycardia exceeding 160 beats per minute after 22 weeks of gestation can be used as evidence of intrauterine thyrotoxicosis. Treatment of the mother with antithyroid medication should be adjusted to maintain a fetal heart rate of 140 beats per minute or so. Untreated, the weight of such infants is often low; the birth may be preterm, with microcephaly and cerebroventricular enlargement. Neonates have hyperphagia, diarrhea, and they may be irritable, with frontal bossing and a triangular facies. If the mother has been on treatment with antithyroid drugs at the end of her pregnancy, clinical signs of neonatal thyrotoxicosis may be unapparent at birth, presenting only a few days after delivery, due to protection of the fetus by the maternal antithyroid drugs. Neonatal hyperthyroidism should be treated promptly with antithyroid medication and blockade. In severely ill infants, propranolol 2 mg/kg/day may be helpful in slowing the heart and reducing hyperactivity. Doses of antithyroid drugs should maintain the maternal free T4 in the upper nonpregnant reference range. Block-and-replace regimens should not be used in pregnancy because carbimazole can cross the placenta but the replacing thyroxin does not; therefore, there is potential for fetal hypothyroidism. Adverse maternal and fetal outcomes secondary to thyroid dysfunction during pregnancy may justify screening for thyroid function early in pregnancy and treating with levothyroxine if the mother is found to be hypothyroid. By contrast, a well-powered study of nearly 22,000 women at 12 weeks of gestation demonstrated no benefit for fetal brain development for screening and management and treatment for maternal hypothyroidism in pregnancy, compared with no screening. It is reported that the mother with positive thyroid peroxidase antibodies is at increased risk of miscarriage even when euthyroid; this intriguing area is under investigation, and no treatment with thyroxin in euthyroid mothers is recommended at present. The definition of sufficient depends on pregnancy; the fetus appears to require near perfect maternal function compared with the nonpregnant state. Primary hypothyroidism is common in women of childbearing age, with a prevalence of 2%­3% of women during pregnancy. Untreated maternal hypothyroidism is associated with an increased risk of obstetric complications and adverse neonatal outcomes. The range for T4 during pregnancy differs from the nonpregnant range, in part due to the doubling of thyroid-binding globulin concentration in pregnancy. If this is a solitary mass, a fine-needle aspiration with cytological examination should be performed. The multidisciplinary team is of utmost importance in the management of thyroid cancer in pregnancy. Thyroid cancer found in pregnancy follows a similar pattern to nonpregnancy states; the prognosis is good for the majority presenting under the age of 40 years. There may be enlargement of nodules during pregnancy and presentation of new nodules,52 and this may be the result of the negative iodine balance that occurs during pregnancy. Surgery for malignant nodules can be normally and safely delayed until after pregnancy. Adrenal disease the maternal adrenal glands do not change morphologically during pregnancy. Maternal glucocorticoid production is up regulated to provide increased concentrations of estrogens and cortisol necessary for the mother and also for fetal development. It increases the rates of spontaneous abortion, perinatal death, premature birth, and intrauterine growth retardation. This can be overwhelmed by excess maternal steroids that, crossing to the fetus, may be associated with intrauterine growth restriction. Pregnancy issues values increase during pregnancy, largely the result of the response to increased cortisol-binding globulin concentrations, induced by rising estradiol levels. In addition the renin­angiotensin­aldosterone pathway is stimulated, accommodating the 50% increase in maternal circulating volume without resulting in hypertension. The diagnosis is often difficult in pregnancy, because dynamic tests may be meaningless due to normal physiological changes in pregnancy. The striae tend to be more pigmented and wider, and they may occur outside of the abdominal wall. Other features include proximal myopathy, hypertension, hirsutism, acne, and bruising. Diagnosis can be difficult in pregnancy, because normal reference ranges vary considerably. An overnight dexamethasone suppression test is not reliable in pregnancy, and false-positive values may occur in pregnancy. The low-dose dexamethasone suppression test is the definitive diagnostic test for the syndrome. Surgery may achieve remission, even with surgery late in the third trimester, but the fetal prognosis remains guarded. Surgery should be considered for adrenal lesions (see section "Pheochromocytoma"). Metyrapone,67,68 a glucocorticoid synthesis inhibitor, has been used successfully in pregnancy, with no reports of congenital malformations. The definitive treatment for pheochromocytoma is surgical removal, ideally before 24 weeks of gestation after -blockade administration, although there is a higher risk of miscarriage in the first trimester. After 24 weeks of gestation, the size of the uterus makes abdominal exploration and resection of the tumor more difficult. Retroperitoneoscopic removal would theoretically seem ideal but has not been utilized in pregnancy, possibly because the uterus is also retroperitoneal. Vaginal delivery has been associated with higher rates of maternal mortality than for caesarean sections,78 which may be the result of catecholamine release secondary to pain and uterine contractions. Pheochromocytoma in pregnancy was previously associated with maternal and fetal mortality rates of up to 50%. They may exhibit unstable hypertension, proteinuria, headaches, sweating, and tachycardia. It may present with a hypertensive crisis, occurring during induction of anesthesia, labor, or surgery. Diagnosis is made with 24 h urine collection for catecholamines and metanephrines. Treatment is in the form of long-term -adrenergic blockade, preferably with phenoxybenzamine that provides long acting, stable, noncompetitive blockade. Phenoxybenzamine crosses the placenta, with some reports of perinatal depression and transient hypotension75; however, other studies have shown it to be safe for the fetus. Risk of transmission to the fetus depends upon the carrier status of the father, and ideally the risk should be assessed before pregnancy. Once the mother is pregnant, prenatal diagnosis of the three enzyme deficiencies is recommended, because prenatal treatment of the neonate with corticosteroid suppression is now possible, to prevent virilization of the affected female fetus. Dexamethasone seems to be associated with a reduction in fetal virilization without significant maternal or fetal adverse effects,81 although some prefer to use hydrocortisone or prednisolone due to reports of low birth weight with dexamethasone. Even if androgen production cannot be suppressed to normal, placental aromatase protects the fetal genitalia and the brain from masculinization. Glucocorticoid supplementation is required during labor as for other causes of glucocorticoid deficiency. If labor is prolonged, the dose of hydrocortisone should be augmented to 100 mg 6 hourly, or as a continuous intravenous infusion (2­3 mg/h). The most common cause of primary adrenal insufficiency in pregnancy is autoimmune in origin. Other causes such as tuberculosis, metastases, hemorrhage, or infarction are rare.

More than 50% of sperm should show forward motility what causes erectile dysfunction in males discount super levitra 80 mg visa, and more than 30% of cells should have normal morphology impotence in men over 60 80 mg super levitra order visa. The presence of leukocytes in the semen does not necessarily indicate accessory gland infection erectile dysfunction treatment in mumbai 80 mg super levitra buy overnight delivery. Hormonal evaluation Semen analysis Three or more semen samples should be obtained by masturbation after a 48 h abstinence period impotence new relationship order 80 mg super levitra otc. In older men with mild hypogonadotropic hypogonadism erectile dysfunction diet pills cheap super levitra 80 mg buy on-line, the search for additional causes of hypogonadotropism is often unrewarding, and the cost-effectiveness of extensive pituitary evaluation has not been established. Older men with severe hypogonadotropic hypogonadism and with serum testosterone levels less than 150 ng/dL (5. In such patients, postejaculatory urine should be checked to exclude retrograde ejaculation, and seminal fructose should be measured. Very low fructose concentrations suggest the absence of seminal vesicles or obstruction. In such patients, exploration and testicular biopsy should be performed to rule out obstruction or germ cell failure. In men who have normal hormone levels and low or normal sperm count, specialized sperm function tests are indicated. Various sperm function tests, including the cervical mucus penetration test, acrosome reaction, zona-free hamster egg penetration test, human zona pellucida binding test, and specialized sperm biochemistry, are used in specialized andrology laboratories. This reaction has good concordance with fertilization in an in vitro fertilization procedure. In all instances, a detailed family history should be obtained, which would then guide genetic testing. Testicular biopsy Although testicular biopsy can provide information about the spermatogenic defect, there are very few instances where this procedure alters the management and prognosis. This individual should undergo further workup to exclude the presence of obstruction, including an examination of postejaculatory urine for sperm and seminal fructose. If seminal fructose is present, testicular biopsy and exploration should be performed to rule out obstruction and establish the presence of spermatogenesis in the testis. Computer-aided sperm analysis Many computer-aided sperm analysis systems are commercially available. These systems are convenient, but they offer no real advantage over manual methods for assessment of sperm morphology. These automated systems are susceptible to error in the estimation of sperm concentration. Approximately 5% of infertile men carry chromosome abnormalities; of these, a majority involve sex chromosomes (4% on average), and 1% involve the autosomes. Men with mosaicism may have germ cells in their testes, especially at a younger age. However, progressive degeneration and hyalinization of seminiferous tubules take place after puberty. Infertile men with azoospermia or severe oligozoospermia in whom the cause of infertility cannot be ascertained should be screened for Y chromosome microdeletions. The mechanism by which an extra X chromosome renders patients infertile is not known. In male germ cells, inactivation of the single X chromosome in primary spermatocytes of heterogametic males is necessary for spermatogenesis to proceed through meiosis. The necessity for X inactivation in male germ cell differentiation in heterogametic species is not clearly understood; however, inactivation of the single X may be necessary for normal sex chromosome pairing or to prevent expression of some X-linked genes that are detrimental to spermatogenesis. In childhood, common presenting features can include delayed speech development, learning difficulties in school, unusually rapid growth in mid-childhood, and truncal obesity. Treatment consists of testosterone therapy to improve virilization, sexual function, bone density, and quality of life. Gynecomastia is treated by cosmetic surgery after androgen replacement therapy has begun. This technique allows for selecting chromosomally abnormal embryos in order to avoid transferring abnormal embryos. The testis size is reduced, the Leydig cell function is impaired, gonadotropins are raised, and there is delayed puberty. The testicular histologies in the small number of reported cases of Y deletions have revealed either Sertoli cells only or germ cell arrest phenotypes. The limited number of patients in whom testicular histology has been examined has not allowed a correlation between the location and size of the deletion and the histological phenotype. The phenotypic males with mixed gonadal dysgenesis often have abdominal testes with normal Leydig cells but without any germ cells. However, because they lack other Y-specific genes required for spermatogenesis, they are sterile. Large deletions of the Y chromosome that can be seen under the microscope in late prophase and hence are detectable on routine karyotype are uncommon in infertile men. However, submicroscopic deletions of the long arm of the Y chromosome, which are not detectable on karyotype and hence are called "microdeletions," are present in 5%­10% of azoospermic men. The initial studies had focused on infertile men with severe defects of spermatogenesis. However, more recent studies have shown that Y deletions are also present in oligozoospermic men. These data suggest that additional Y-specific and autosomal genes may be involved in other infertility phenotypes. However, several reports indicate that men with idiopathic oligozoospermia have a higher likelihood of having longer polyglutamine tracts than fertile men. These authors have proposed that long polyglutamine tracts are associated with increased risk of infertility and reduced risk of prostate cancer. Conversely, these authors assert that short polyglutamine tracts are associated with increased transactivational activity, increased risk of prostate cancer, and reduced risk of infertility. About 50% are homozygous for a common cystic fibrosis gene abnormality such as F508, and some have compound heterozygosity. Gonadal dysfunction associated with sickle cell disease and thalassemia A significant proportion of men with sickle cell disease have low testosterone levels. The majority of men with sickle cell disease and low testosterone levels suffer from primary testicular dysfunction. However, hypogonadotropic hypogonadism due to hypothalamic­ pituitary dysfunction has also been reported in men with sickle cell disease. The pituitary and gonadal dysfunction occurs in thalassemia due to iron deposition in these tissues. Pituitary and testicular overload and the resulting hypogonadism can be prevented by prophylactic iron-chelating therapy. Testicular atrophy occurs in 75% of these men, primarily due to degeneration of the seminiferous tubules. Although Leydig cells are preserved, serum testosterone levels are low in many patients due to primary testicular failure. Similarly, it is also useful to quickly ascertain whether the patient has untreatable sterility in which case the couple should be appropriately counseled about adoption or artificial insemination with donor sperm. One of the most useful roles that an internist can play is to present to the couple a realistic prognosis, the pros and cons of different treatment options, and estimates of costs, and to guide the couple away from interventions that have not been shown to be effective (Table 17. Subfertility associated with diabetes Men with diabetes mellitus may experience infertility if they have retrograde ejaculation due to autonomic neuropathy or if they have poor glycemic control. Preparations Treatment the role of the internist in the management of the infertile couple the internist can play an important role in the treatment of infertile men by initiating a rational diagnostic evaluation and referring those who require more specialized care. It should be noted that the biphasic testosterone and estradiol responses are characteristic of only postpubertal, normally virilized men. The two best predictors of success of gonadotropin therapy in hypogonadotropic men are testicular volume at presentation and the time of onset of hypogonadotropism (prepubertally or postpubertally). In general, the larger the testis size, the greater the likelihood of success; best responses are seen in men with initial testicular volume greater than 8 mL. Although a variety of treatment regimens are being used, there is no consensus on what constitute the optimum dose and schedule of gonadotropin administration. It may take several82,282­284 months for spermatogenesis to be restored, and patients often get very impatient and prematurely disappointed. Therefore, it is very important to forewarn patients about the potential length and expense of the treatment, and to provide conservative estimates of success rates. It may occasionally take 18­24 months or longer for spermatogenesis to be restored. Prior androgen therapy appears not to affect subsequent responsiveness to gonadotropin therapy. In general, men with testicular volumes greater than 8 mL have higher response rates than those with testicular volumes less than 4 mL. Testicular volume increased threefold during treatment, and 80% of men who were initially azoospermic achieved a positive sperm count. The sperm concentrations in all men were below 5 × 106/mL and were comparable in the two groups. Spermatogenesis was induced in 54 of 57 courses of therapy, and pregnancies occurred in 26 of 36 courses. The two therapies did not significantly differ in terms of the time to first appearance of sperm or pregnancy rates. Also, it is best to present a realistic prognosis and dampen expectations at the very outset. Varicoceles are present in 10%­30% of infertile men; however, they are also common in men of known fertility. Only a few controlled clinical trials have been performed, and these trials have failed to show significantly greater improvements in fertility after surgical resection of varicoceles than after counseling alone. The expert opinion among urologists favors surgical correction of varicoceles in adolescent boys; the rationale is that there is catch-up growth of the testes after varicocelectomy which might not occur without the surgical correction. Azoospermia the presence of azoospermia, total teratozoospermia, and primary testicular failure with azoospermia indicates a poor prognosis. These investigators report clinical pregnancy rates of 49% for nonobstructive cases and 57% for testicular spermatozoa obtained from men with obstructive azoospermia. Eighty to ninety percent of couples had embryo transfer, and the viable pregnancy rates were 21% for ejaculated, 22% for epididymal, and 19% for testicular sperm. When multiplicity is taken into account, the incidence of major or minor malformations is not increased. Data from the Swedish Medical Birth Registry264,311 have also demonstrated an increase in relative risk of hypospadias. Testosterone deficiency in young men: Marked alterations in whole body protein kinetics, strength, and adiposity. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men [published erratum appears in J Clin Endocrinol Metab 1994; 78(6): 1520]. The effects of testosterone replacement on nocturnal penile tumescence and rigidity and erectile response to visual erotic stimuli in hypogonadal men. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: Effects of androgens. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling. Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men An examination of research design effects on the association of testosterone and male aging: Results of a meta-analysis. Characteristics of androgen deficiency in late onset hypogonadism: Results from the European Male Aging Study. Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Sexual function and hormonal abnormalities in uremic men on chronic dialysis and after renal transplantation. Rationale for anabolic therapy to facilitate rehabilitation in chronic obstructive pulmonary disease. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels. Regulation of alpha and rat luteinizing hormone-beta messenger ribonucleic acids during gonadotropin-releasing hormone agonist treatment in vivo in the male rat. Effects of treatment with various doses of haloperidol on the pituitary­gonadal axis in male schizophrenic patients. Accelerated osteoporosis in psychiatric patients: Possible pathophysiological processes. Longitudinal evaluation of serum androgen levels in men with and without prostate cancer. Sex hormones and age: A cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. Effects of testosterone replacement therapy in old hypogonadal males: A preliminary study. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial.

Order 80 mg super levitra free shipping. Erectile Dysfunction and Diabetes.

In case of a large tumor burden impotence over 40 purchase 80 mg super levitra otc, to limit adverse events erectile dysfunction pills supplements generic super levitra 80 mg on-line, two sessions (4­8 weeks between) should be performed erectile dysfunction images 80 mg super levitra for sale. Their numbers are growing-perhaps in part due to better recognition-but their quite high prevalence ensures the need for dedicated multidisciplinary groups to streamline management of these patients rogaine causes erectile dysfunction super levitra 80 mg order line. Nonetheless erectile dysfunction due to zoloft quality super levitra 80 mg, even better and clearer nomenclature will need to be developed to ensure clearer and rapid data capture. Surgical strategies have become clearer, and pancreatic-sparing procedures have been better defined in high-volume centers to allow for limited resections in certain individuals. As with other areas in modern oncology, identification of novel and specific molecular targets capable of predicting therapeutic responses will help streamline and tailor therapies in this field. Incidental detection of pancreatic neuroendocrine tumors: An analysis of incidence and outcomes. Chromogranin A: Its role in endocrine function and as an endocrine and neuroendocrine tumor marker. One hundred years after "carcinoid": Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Classic and recent special stains used in differential diagnosis of endocrine tumors. Neuroendocrine tumors of midgut and hindgut origin: Tumor-node-metastasis classification determines clinical outcome. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms. Sanduleanu S, De Bruine A, Stridsberg M, Jonkers D, Biemond I, Hameeteman W, et al. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Chromogranin A as serum marker for neuroendocrine neoplasia: Comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. Quantitative ultrastructure of endocrine cells of oxyntic mucosa in Zollinger-Ellison syndrome. Acidic catecholamine metabolites and 5-hydroxyindoleacetic acid in urine: the influence of diet. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the ZollingerEllison syndrome. Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Value of somatostatin receptor scintigraphy: A prospective study in gastrinoma of its effect on clinical management. Detection of liver metastases from endocrine tumors: A prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: Implications for follow-up after therapy. Diagnosis of neuroendocrine tumours by retrospective image fusion: Is there a benefit Consensus guidelines for the management of patients with digestive neuroendocrine tumors - well-differentiated jejunal-ileal tumor/carcinoma. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors. Consensus guidelines for the management of patients with digestive neuroendocrine tumours: Well-differentiated colon and rectum tumour/ carcinoma. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours. Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: Foregut, midgut, hindgut, and unknown primary. Two-step surgery for synchronous bilobar liver metastases from digestive endocrine tumors: A safe approach for radical resection. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors-the International Lanreotide and Interferon Alfa Study Group. Summing up 15 years of somatostatin analog therapy in neuroendocrine tumors: Future outlook. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Antitumour activity of somatostatin analogues in progressive metastatic neuroendocrine tumours. Treatment of carcinoid syndrome: A prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Treatment of the carcinoid syndrome with the long acting somatostatin analogue lanreotide: A prospective study in 39 patients. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. Octreotide acetate longacting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide. Rapid and sustained relief from the symptoms of carcinoid syndrome: Results from an open 6-month study of the 28-day prolongedrelease formulation of lanreotide. Long-term results of treatment of malignant carcinoid syndrome with prolonged release Lanreotide (Somatuline Autogel). Gastrointestinal side-effects of octreotide during longterm treatment of acromegaly. The ZollingerEllison syndrome: Dangers and consequences of interrupting antisecretory treatment. The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Liver metastases of neuroendocrine carcinomas: Interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: A prospective randomized study. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: Early results in 148 patients. Most patients with a hereclitary form of the clisease have a family history suggestive of the disease, however, isolated cases may also have a genetic predisposition due to a de novo mutation or a somatic/germline mosaic state. Tumor genes Tumors are the result of a multistep process involving mutations in several different cancer genes that lead to increased cell proliferation, prolonged cell survival, accumulation of mutations, and resistance to programmed cell death or apoptosis. They are drivers of cell division; thus, an activating mutation in one copy of the gene is sufficient to stimulate cell growth or survival. In these families, tumors are typically present in several generations and affect men and women equally often. Ascertain whether the same individual or first-degree relatives have any other endocrine tumors or other associated manifestations and perform the appropriate genetic testing. There is often no known family history suggestive of the disease in older generations; however, several siblings may be affected. To date, no hereditary endocrine tumor syndromes with an autosomal recessive pattern of inheritance have been identified. Lastly, tumors may be inherited in an X-linked manner, where a carrier mother has a risk of having an affected son. Because there is a high likelihood of the second mutation occurring in several different cells independently of each other, there may be multicentric tumor growth. If possible, the diagnoses of the close relatives are confirmed by obtaining their permission to access information from the cancer registry, copies of their medical records, or both. Based on the pedigree information, a genetic diagnosis may be suspected and the appropriate genetic testing offered to an affected individual. There are several large databases with information on normal variants in genes. Today mutations are denoted in relation to the first base in the coding sequence. Once a mutation is detected, the index patient is urged to spread the information to close relatives at risk of developing the condition. Mutation carriers are offered a surveillance program with the aim of detecting tumors at an early stage where curative therapy is possible. Generally, minors are only tested if there is a risk of childhood cancer that will benefit from surveillance as is the case in hereditary endocrine neoplasia (see below). The advantages of presymptomatic genetic testing include optimal treatment of tumors, inclusion in surveillance program/prophylactic measures, and the possibility of prenatal diagnosis (see below). Non-carriers can also be excluded from surveillance programs and unnecessary anxiety. In addition, stigmatisation in social or work life and/or possible problems with insurance companies (health/life insurance) should be addressed. Simultaneously, a test to exclude maternal cell contamination of the sample is performed using a blood sample from the mother (or results saved from a previous blood sample from the mother). The embryos are cultured for a few days in the laboratory, and when they reach the eight-cell stage, a single cell can be removed and used for genetic diagnosis. The method was first introduced in 1990, and so far no major complications have been monitored. It is important to check plasma levels of gastrin and to perform the secretin provocation test before pancreatic surgery because the presence of gastrinomas requires specific surgical procedures. Before the introduction of surveillance programs, metastasis was present upon diagnosis in half of the cases. The average age of onset is 38 years, but they have been found in children as young as 5 years. Pituitary tumors occur in approximately 1/1000 individuals in the general population16; 2. Foregut carcinoids arise in the embryonic tissues that develop from the foregut, that is, the thymus, respiratory tract, and ventricle. Foregut carcinoids seldom oversecrete hormones, and the clinical carcinoid syndrome is rarely seen. Thymic carcinoids are more common in men, especially if they are smokers and occur in 2. Their growth is stimulated by hypergastrinemia that, in turn, may be the result of a gastrinoma Foregut carcinoids or gastric achlorhydria induced by proton pump inhibitor treatment. They are generally diagnosed later (mean age, 46 years) and are the presenting lesion in only 6%. They are generally nonfunctional, although 15% may have oversecretion of cortisol or aldosterone. The viability of the remaining parathyroid remnant (taken from the smallest gland) should be confirmed before removing the other glands. In addition, it should be marked with a suture or clip and sewn away from the laryngeal nerve to reduce risk of hoarseness upon reoperation. Because parathyroid remnants may succumb to necrosis, parathyroid tissue should be cryopreserved if possible. Total parathyroidectomy with autotransplantation of parathyroid tissue may be required in cases with advanced involvement of all four glands, but because 35% develop hypoparathyroidism and recurrence occurs in up to 17%, most surgeons do not choose total parathyroidectomy as a first-hand option. Annual postoperative follow-up should be performed to exclude recurrence (Table 9. In contrast, reoperation (with ensuing increased morbidity) is more likely to be required after early surgery. If the mother or the fetus develops symptoms, surgical removal of the parathyroid gland is recommended in the second trimester. Partial pancreatic resection, with or without duodenectomy, has a higher risk of recurrence (up to 78% in the case of gastrinoma),25 whereas removal of the entire pancreas causes severe diabetes. Due to the simultaneous loss of insulin, glucagon, and pancreatic polypeptide, the diabetes is difficult to treat and has an increased risk of hypoglycemia and cerebral insult. Medical treatment with proton pump inhibitors, somatostatin analogs, or both is successful against hormone overproduction and may also reduce tumor growth. For gastrinomas, there is evidence that some have an indolent course (even after lymph node metastasis), whereas others have rapid tumor progression and poorer prognosis. The surgical procedure that most surgeons recommend is resection of the most affected part of the pancreas with enucleation of tumors >5 mm in the remaining pancreatic tissue and regional lymphadenectomy. Preoperative gastrin levels should be ascertained, because if gastrinoma is present, it is likely to be located in the duodenum (see section "Clinical features"); therefore, surgery should include the duodenum. In this case, there are two main recommended surgical procedures: (1) enucleation of smaller duodenal gastrinomas, or excision of the duodenal wall Enteropancreatic endocrine tumors (see Chapter 8) Pituitary tumors (see Chapters 1, 3, 4) the surgical and medical management follows the conventional approaches for functioning and nonfunctioning pituitary tumors. Prolactinomas are generally treated with dopamine agonists that reduce the levels of prolactin. Transsphenoidal surgery is reserved for dopamine-resistant cases, and radiotherapy may be used after noncurative surgery. Endoscopic resection may be possible if they do not involve the muscular layer of the stomach wall. Upon recurrence or if malignant, partial or total gastrectomy with lymph node dissection may be performed.

In the testis erectile dysfunction caused by low blood pressure super levitra 80 mg buy free shipping, this gonadotropin plays a central role in testicular development and spermatogenesis (Huhtaniemi erectile dysfunction drugs with the least side effects order 80 mg super levitra, 2015) cost of erectile dysfunction injections effective 80 mg super levitra. The a-subunit may be secreted and in certain circumstances may achieve high concentrations in the blood erectile dysfunction treatment clinics buy 80 mg super levitra free shipping, but no function for the free subunit has been demonstrated erectile dysfunction quran purchase 80 mg super levitra otc. The b-subunit is unique to each glycosylated hormone and, when associated with the a-subunit, confers biologic activity on the hormone (Berger and Lapthorn, 2016). Carbohydrate groups are present at specific locations on each subunit with two oligosaccharide moieties on each subunit (Bousfield and Dias, 2011). The oligosaccharide moieties are coupled through N-acetylglucosamine to specific asparagine groups in the aand b-subunits. The oligosaccharides contain the monosaccharides mannose, galactose, glucosamine, N-acetylgalactosamine, and sialic acid. In addition, the oligosaccharides are branched and heterogeneously terminate mainly in sialic acid and fucose. These differences are largely responsible for the variation in the isoelectric point (4. Manuela Simoni, Livio Casarini, and Daniele Santi introduced the abstract, updated all sections and references. These vessels constitute a specialized form of the circulatory system, called "portal system. Like all members of this family it is characterized by seven transmembrane domains, totally of 264 amino acids. These hydrophobic stretches are of 21­24 amino acids connected by intracellular and extracellular loops (Simoni et al. Upon hormone binding, the receptor undergoes a conformational change leading to dissociation of G protein heterotrimer at the intracellular level, thus inducing signal transduction. Ribbon diagram of the complex structure shown in two views related by a 90 degree rotation about the vertical axis (panel A and B). It is located in the promoter region of the receptor gene modulating the transcription levels of the gene (Desai et al. N680S was discussed, as well as their role in the evolution of different endocrine phenotypes among humans was suggested (Simoni and Casarini, 2014). An example of inactivating mutation is given by the C to T nucleotide point mutation found in Finnish families (Aittomaki et al. The women of these families have hereditary hypergonadotropic ovarian failure, with amenorrhea and atrophic ovaries with follicles that do not develop beyond primary follicles. Men homozygous for this mutation are normally virilized and have sufficient testosterone to initiate and maintain spermatogenesis, although displaying variable degrees of spermatogenic failure (Tapanainen et al. It was an aspartic acid to glycine substitution at position 566 displaying constitutive activity in vitro. Especially, five inactivating mutations leading to the insertion of a stop codon or to a loss of residual cysteine were described so far (La Marca et al. All these mutations compromise the subunit folding and lead to abnormal puberty or primary amenorrhea in women, and altered pubertal development and azoospermia in men. During fetal development of the female mammal, the primitive germ cells in the ovary enter meiosis and arrest in the prophase of meiosis I. During fetal life in primates and ruminants and within the first 2 weeks after birth in rodents, some of the primordial follicles are activated and become primary follicles. The mechanisms stimulating the primordial follicles to initiate folliculogenesis are unknown, but are clearly independent of gonadotropin action. The outermost layer is composed of theca cells that are separated from the innermost layer, comprising granulosa cells, by a basement membrane. Both types of cells proliferate, increasing the size of the follicle until a fluid-filled cavity, or antrum, forms in the layers of the granulosa cells. The mature, or antral, follicle ruptures, marking the end of folliculogenesis and representing the ovulation phase, results in releases of the oocyte and some of the granulosa cells surrounding it. The theca and granulosa cells remaining in the ruptured follicle differentiate into luteal cells, forming the corpus luteum that characterizes the luteal phase of the ovarian cycle. The rapid involution of the corpus luteum is called luteolysis and is regulated by specific factors. As the follicle enlarges, a cavity forms around the oocyte so that layers of granulosa cells and fluid surround it, but a peduncle of granulosa cells remains attached to the rest of the follicle. This capacity is defined as the number of sperm potentially produced by the male gonad and intuitively this must directly relate to the number of spermatogenetic stem cells and the capacity of the structure of the gonad to nourish and support the progeny of these stem cells. The Sertoli cells of the mammalian testis are the only somatic cells in the seminiferous epithelium and are known to proliferate only during fetal and peripubertal development in rodents. A third period of Sertoli cell proliferation occurs during infancy in higher primates. After these, somatic cells have attained a population size associated with adulthood, proliferation ceases, and the cells terminally differentiate. The mature Sertoli cells serve to organize and nourish the germ cells that make up the remainder of the cell types in this epithelium. Spermatogenesis is a complex process occurring in the seminiferous tubules, with the final outcome of the mature male gamete production. This network comprises several phases, such as spermatogonia proliferation, spermatogonial differentiation into spermatocytes, spermatocytes meiotic division producing spermatids, maturation of round spermatids; and the release of highly specialized mature spermatozoa into the testicular tubule lumen (Neto et al. This process is allowed by the stem cell continuous renewal, which ensures a large and undiminishing number of undifferentiated germ cells available for the subsequent waves of spermatogenesis (Heller and Clermont, 1963; Misell et al. The spermatogenetic stem cells are called type A spermatogonia, which are continuously renewed and differentiate forming type B spermatogonia. The entire spermatogenic process requires approximately 74 days, varying between 42 and 76 days, with an overall daily production from 150 to 275 millions of sperms (Misell et al. In this process, several testicular structures are involved, from which Sertoli cells are indispensable for spermatogenesis (Neto et al. The importance of pituitary in stimulating spermatogenesis was demonstrated by hypophysectomy of adult rats, which led to a decrease in testicular weight and impairment of germ cells maturation to spermatids. Hypophysectomy of adult rhesus monkeys resulted in a precipitous decline in testicular size associated with the complete regression of the seminiferous epithelium to the extent that the tissue comprised only Sertoli cells and type A spermatogonia. Therefore, gonadal growth was due primarily to the stimulation of spermatogenesis by androgen, but morphometric analysis of the seminiferous epithelium of the monkeys revealed that the smaller testicular size was accounted for by a deficit in the numbers of all type B spermatogonia. Unilateral orchidectomy in adult macaques results in a compensatory growth of the remaining testis. The number of Sertoli cells per testis was identical in the gonad removed at the time of unilateral orchidectomy and the gonad that remained in the animal for 45 days. The number of all germ cells more mature than type A (subtype "p"; Ap) spermatogonia was greater in the remaining testis than in the removed testis. The removal of one gonad in these primates was marked also by a decline in inhibin B, which is secreted by Sertoli cells into the circulatory system. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: Potential role of an analog of the retinal protein arrestin (48-kDa protein). Proceedings of the National Academy of Sciences of the United States of America 84, 8879­8882. Genetic variation of follicle-stimulating hormone action is associated with age at testicular growth in boys. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in granulosa cells. Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Proceedings of the National Academy of Sciences of the United States of America 109, E2979­88. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. A stable isotope-mass spectrometric method for measuring human spermatogenesis kinetics in vivo. The effects of kisspeptin in human reproductive function-Therapeutic implications. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. Prolactin: Regulation of Secretion and Action Filippo Maffezzoni, University of Brescia, Brescia, Italy Gherardo Mazziotti, Carlo Poma Hospital, Mantova, Italy Andrea Giustina, San Raffaele Vita-Salute University, Milan, Italy r 2018 Elsevier Inc. Glossary Cathepsin Cathepsins are proteases (enzymes that degrade proteins) found in all animals as well as other organisms. Kallikrein Kallikreins are a subgroup of serine proteases, enzymes capable of cleaving peptide bonds in proteins. Lactotropes represent 40%­50% of the total pituitary cell population and are mostly aggregated in the postero-lateral areas of the gland. The left and right arrows in the upper panel designate extrapituitary and pituitary transcription start sites, respectively, and the numbers designate the exons. For instance, kallikrein and cathepsin D were shown to produce the 22 and 16 kD fragments, respectively, which may be important in regulating non reproductive functions (see, section on physiological actions). Endocrine regulators originate from the hypothalamus and the peripheral glands and reach the lactotrophs via the blood. Paracrine factors reach the lactotropes by diffusion from neighboring pituitary cells. This effect was shown to be often transient resolving spontaneously in about 50% of women (Luciano et al. Interestingly, the effect of adrenalectomy were reversed by the administration of exogenous corticosteroids. Gonadal Effects While hyperprolactinemia effects on gonadal function are well known in males and females (Mancini et al. This mechanism is more easily detectable during the late stage of pregnancy, facilitating the subsequent lactation. These actions are important during pregnancy and lactation with adaptive changes in lipid metabolism and glucose homeostasis (Ladyman et al. All these effects are important for guaranteeing adequate calcium levels for fetal development during pregnancy and breastfeeding during lactation. Physiological role of galanin in the regulation of anterior pituitary function in humans. Prolactin receptor expression in human testis and accessory tissues: Localization and function. Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma. High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Evidence for direct effects of prolactin on human osteoblasts: Inhibition of cell growth and mineralization. Increased plasma/serum levels of prolactin in systemic lupus erythematosus: A systematic review and meta-analysis. Prolactin-mediated inhibition of 20 alpha-hydroxysteroid dehydrogenase gene expression and the tyrosine kinase system. Glossary Adenohypophysial Pertaining to the adenohypophysis or anterior pituitary. Epigenetic Functionally relevant changes to the genome that do not involve changes to the nucleotide sequence. Introduction this article is an update of Shereen Ezzat, Pituitary Tumors, Molecular Pathogenesis, In Encyclopedia of Endocrine Diseases, edited by Luciano Martini, Elsevier, New York, 2004, Pages 681-686. Pituitary tumors are common neoplasms that exhibit a wide range of biological courses as evidenced by hormonal and proliferative activities (Asa et al. Traditionally, there was an on-going controversy regarding the basis of pituitary tumorigenesis. Two prevailing theories confronted hormonal stimulation as an extrinsic stimulus against a somatic mutation as an intrinsic pituitary defect. While a minority of these tumors harbors genetic mutations, several animal models and unique clinical cases have provided support for hormonal stimulation in the development of these tumors. These findings along with evolving experimental evidence favor a theory that accounts for epigenetic dysregulation of the balance between stimulatory and inhibitory influences, irrespective of their origin (Asa, 2011; Asa and Ezzat, 2009). In this review, we highlight recent insights into mechanisms implicated in the dysregulated balance of signals that control pituitary adenohypophysial cell growth and function. Pituitary Tumor Classification by Cytogenesis Pituitary tumors have been recognized to produce hormones and immunohistochemistry has complemented the clinical measurement of circulating hormone excess to classify pituitary tumors that cause hormone excess. Morphologically, classification of such tumors entails the identification of subcellular features that identify the cell lineage, transcription factors, hormones, and other structural parameters (Asa, 2011) that indicate altered signaling pathways. Similarly, although most tumors that are called "prolactinoma" represent sparsely granulated lactotroph tumors, those with unusual clinical manifestations and that fail to respond to dopaminergic agents are frequently discovered to be rare variants such as acidophil stem cell or poorly differentiated Pit-1 lineage tumors (Gomez-Hernandez et al. In patients with Cushing disease, there are several morphologic variants; the classical microadenoma that causes florid Cushingoid features is usually a densely granulated tumor, whereas the sparsely granulated tumors are usually large when discovered and may not be associated with obvious hypercortisolemia, a phenomenon that has been called a "whispering" rather than "silent" tumor. The vast majority of these is now known to be of gonadotroph differentiation; although functioning gonadotroph tumors are rare, the silent tumors usually have focal gonadotropin reactivity and with the use of immunohistochemistry for steroidogenic factor-1, are proven to be of gonadotroph lineage (Asa, 2011). However, those that are not, whether they are silent corticotroph tumors, silent tumors of Pit-1 lineage, or true "null cell" adenomas that have no evidence of any lineage differentiation, are more aggressive (Nishioka et al. This article is an update of Shereen Ezzat, Pituitary Tumors, Molecular Pathogenesis, In Encyclopedia of Endocrine Diseases, edited by Luciano Martini, Elsevier, New York, 2004, Pages 681­686. Pituitary stem cells differentiate along three major pathways of pituitary differentiation that are determined by expression of transcription factors (italics); the Pit-1 lineage is more complex, giving rise to four cell types again determined by expression of additional transcription factors.

References

• Kamiya H, Shinoda K, Kobayashi N, et al. Tuberous sclerosis complex complicated by pulmonary multinodular shadows. Intern Med 2006;45:275-8.
• Kirshblum S, O'Dell MW, Ho C, et al. Rehabilitation of persons with central nervous system tumors. Cancer 2001;92(4 suppl):1029-1038.
• Wolf H, Schaap AH, Bruinse HW et al. Vaginal delivery compared with caesarean section in early preterm breech delivery: a comparison of long term outcome. Br J Obstet Gynaecol 1999; 106: 486-91.
• Silverstein, B. A. (1985). The prevalence of upper extremity cumulative trauma disorders in industry. Unpublished Ph.D. thesis, University of Michigan, Ann Arbor.
• Turk C, Petrik A, Sarica K, et al: EAU guidelines on interventional treatment for urolithiasis, Eur Urol 69(3):475n482, 2016.